<DOC>
	<DOCNO>NCT00402389</DOCNO>
	<brief_summary>This study evaluate effectiveness use omega-3 fatty acid treat woman perinatal depression .</brief_summary>
	<brief_title>Use Omega-3 Fatty Acids Perinatal Depression</brief_title>
	<detailed_description>Depression chief cause disease-associated disability woman . Because high low pregnancy first year motherhood , expectant new mother particularly prone depression . Approximately 10 % 15 % woman experience perinatal depression , include depression pregnancy and/or postpartum depression . Signs perinatal depression include persistent feeling anxiety , guilt , hopelessness ; irregular sleep appetite pattern ; lethargy ; disinterest infant family activity ; excessive irritability restlessness ; thought hurt self infant ; inability concentrate ; lack enjoyment previously enjoy activity . Depression occur pregnancy postpartum negative impact development health baby . Additionally , maternal stress human associate low birth weight low gestational age birth . Currently , lack knowledge use antidepressant pregnancy postpartum , make significant health issue . Earlier study suggest depletion omega-3 fatty acid pregnancy might cause depression mood disorder pregnant woman . This study evaluate effectiveness use omega-3 fatty acid treat woman perinatal depression . Participation double-blind study last 9 week . All participant attend initial screen visit subsequent study visit , occur bi-weekly throughout treatment phase . During visit , participant ask question medical substance use history , demographic information , eat behavior . Participants also complete questionnaire interview use assess mental status , depression level , marital/partner satisfaction level , social/functional ability , overall mood level . After initial screen visit , eligible participant randomly assign receive either omega-3 fatty acid placebo capsule . Participants group require take four capsule daily basis 8 week . During treatment phase , participant also attend six weekly 30-minute supportive psychotherapy session . Blood sample omega-3 fatty acid analysis take first last visit .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Asphyxia Neonatorum</mesh_term>
	<criteria>Women pregnant ( 12 32 week gestation ) postpartum Meets criterion major depressive episode Scores minimum 9 Edinburgh Postnatal Depression scale Must able treat outpatient basis Known intolerance allergy omega3 fatty acid fish oil Presently take antidepressant medication Currently use heparin warfarin ( compound use prevent blood clot ) Presence psychotic symptom History mania ( abnormally elevate mood state ) hypomania ( mania occurs much less degree ) Active suicidal ideation ( desire commit suicide )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Perinatal Depression</keyword>
	<keyword>Postpartum Depression</keyword>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>Eicosapentaenoic Acid ( EPA )</keyword>
	<keyword>Docosahexaenoic Acid ( DHA )</keyword>
	<keyword>Pregnancy</keyword>
	<keyword>Psychotherapy</keyword>
</DOC>